19-1220389-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP5
The NM_000455.5(STK11):c.481A>T(p.Ile161Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.481A>T | p.Ile161Phe | missense_variant | Exon 4 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.481A>T | p.Ile161Phe | missense_variant | Exon 4 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1748A>T | non_coding_transcript_exon_variant | Exon 5 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.481A>T | p.Ile161Phe | missense_variant | Exon 4 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.481A>T | p.Ile161Phe | missense_variant | Exon 4 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.109A>T | p.Ile37Phe | missense_variant | Exon 6 of 12 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This variant is denoted STK11 c.481A>T at the cDNA level, p.Ile161Phe (I161F) at the protein level,and results in the change of an Isoleucine to a Phenylalanine (ATT>TTT). This variant has been observed in at leastone family meeting clinical diagnostic criteria of Peutz-Jeghers Syndrome (Borun 2013). STK11 Ile161Phe was notobserved in large population cohorts (NHLBI Exome Sequencing Project, The 1000 Genomes Consortium 2015, Lek2016). Since Isoleucine and Phenylalanine share similar properties, this is considered a conservative amino acidsubstitution. STK11 Ile161Phe occurs at a position where amino acids with properties similar to Isoleucine aretolerated across species and is located within the Protein kinase domain (UniProt). In silico analyses are inconsistentregarding the effect this variant may have on protein structure and function. Based on the currently available evidenceand internal data, we consider STK11 Ile161Phe to be a likely pathogenic variant -
Peutz-Jeghers syndrome Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.I161F variant (also known as c.481A>T), located in coding exon 4 of the STK11 gene, results from an A to T substitution at nucleotide position 481. The isoleucine at codon 161 is replaced by phenylalanine, an amino acid with highly similar properties. This alteration was detected in one patient meeting diagnostic criteria for Peutz-Jeghers syndrome (PJS), however clinical details were limited (Borun P et al. BMC Med. Genet., 2013 May;14:58). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6316 samples (12632 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than 125000 alleles tested) in our clinical cohort. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at